Guides

TRT guides: labs, injection timing and protocol tracking

Six guides for men who want to understand their own bloodwork and their own protocol well enough to have a better conversation with their clinician. No dosing advice, no outcome promises — every factual claim cites a primary source.

TRT AI editorial team· Updated · 4 min read·Informational, not medical advice

Informational only

This page is educational. It is not medical advice, it is not a dosing instruction, and it is not a substitute for the clinician who prescribes and monitors your therapy. TRT AI is a tracking tool: it records what you were prescribed and what your labs said. It does not recommend, calculate or adjust medication doses. Never start, stop or change a protocol — or act on a lab value — without the clinician who ordered it.

On this page

  1. The guides
  2. How to use these with the calculators
  3. What these pages will and will not do
  4. Who writes this

The guides

How to use these with the calculators

Each guide pairs with one of the free browser tools, because a number is easier to understand when you can move the inputs and watch it change. Nothing is stored on a server, and none of them require an account.

A reasonable path through the material: start with what the markers mean, then when to draw them, then the specific marker you have a question about — estradiol, free testosterone and SHBG or hematocrit. The injection frequency guide explains why the timing of everything else matters in the first place.

What these pages will and will not do

TRT is a domain where confident bad information is abundant and cheap. The rules these pages follow are therefore deliberately narrow:

If you are looking for a protocol, this is the wrong site. If you are looking to understand the numbers you already have well enough to ask better questions, keep reading.

Who writes this

These pages are written and maintained by the TRT AI editorial team — the people who build the app, not clinicians. That is exactly why they describe, cite and defer rather than advise. Nothing here has been reviewed as clinical guidance, and it should not be read as such.

Corrections are genuinely welcome, particularly on sourcing: contact@trtai.app.

Sources

  1. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744. pubmed.ncbi.nlm.nih.gov/29562364/
  2. American Urological Association. Evaluation and Management of Testosterone Deficiency (2018; reviewed and validity confirmed 2024). www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
  3. DEPO-TESTOSTERONE (testosterone cypionate) injection, solution — FDA-approved label, Pharmacia & Upjohn Company LLC. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=735b5bf3-4464-412c-a072-1bd02f2e5380

Sources were checked on 25 July 2026. Guideline documents are revised — always read the current version, and read it with the clinician who knows your case.